Literature DB >> 12654856

Interleukin-10 negatively regulates local cytokine and chemokine production but does not influence antibacterial host defense during murine pneumococcal meningitis.

Petra J G Zwijnenburg1, Tom van der Poll, Sandrine Florquin, John J Roord, A Marceline van Furth.   

Abstract

To determine the role of endogenous interleukin-10 (IL-10) in local host defense during pneumococcal meningitis, the inflammatory responses of IL-10-gene-deficient and wild-type mice after the induction of meningitis were compared. The absence of IL-10 was associated with higher cytokine and chemokine concentrations and a more pronounced infiltrate, but antibacterial defense or survival was not influenced.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12654856      PMCID： PMC152042          DOI： 10.1128/IAI.71.4.2276-2279.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis.

Authors:  M Deckert; S Soltek; G Geginat; S Lütjen; M Montesinos-Rongen; H Hof; D Schlüter
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines.

Authors:  F Molina-Holgado; R Grencis; N J Rothwell
Journal:  Glia       Date:  2001-02       Impact factor: 7.452

3.  Emergence of vancomycin tolerance in Streptococcus pneumoniae.

Authors:  R Novak; B Henriques; E Charpentier; S Normark; E Tuomanen
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

Review 4.  Interleukin-10 in the brain.

Authors:  K Strle; J H Zhou; W H Shen; S R Broussard; R W Johnson; G G Freund; R Dantzer; K W Kelley
Journal:  Crit Rev Immunol       Date:  2001       Impact factor: 2.214

5.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

6.  Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.

Authors:  I P Oswald; T A Wynn; A Sher; S L James
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 7.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra
Journal:  Immunol Today       Date:  1992-06

8.  High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis.

Authors:  A M van Furth; E M Seijmonsbergen; J A Langermans; P H Groeneveld; C E de Bel; R van Furth
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

Review 9.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

10.  Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system.

Authors:  P Gallo; S Sivieri; L Rinaldi; X B Yan; F Lolli; A De Rossi; B Tavolato
Journal:  J Neurol Sci       Date:  1994-10       Impact factor: 3.181
View more
  13 in total

Review 1.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

3.  Long-term flaxseed oil supplementation diet protects BALB/c mice against Streptococcus pneumoniae infection.

Authors:  Archana Saini; Kusum Harjai; Harsh Mohan; Raj Pal Singh Punia; Sanjay Chhibber
Journal:  Med Microbiol Immunol       Date:  2009-11-17       Impact factor: 3.402

Review 4.  Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.

Authors:  Mazen M Jamil Al-Obaidi; Mohd Nasir Mohd Desa
Journal:  Cell Mol Neurobiol       Date:  2018-08-16       Impact factor: 5.046

Review 5.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Lymphocytes modulate innate immune responses and neuronal damage in experimental meningitis.

Authors:  Olaf Hoffmann; Olga Rung; Josephin Held; Chotima Boettcher; Stefan Prokop; Werner Stenzel; Josef Priller
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

Review 7.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Edaravone attenuates hippocampal damage in an infant mouse model of pneumococcal meningitis by reducing HMGB1 and iNOS expression via the Nrf2/HO-1 pathway.

Authors:  Zheng Li; Qian-Qian Ma; Yan Yan; Feng-Dan Xu; Xiao-Ying Zhang; Wei-Qin Zhou; Zhi-Chun Feng
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

9.  Characterization of a pneumococcal meningitis mouse model.

Authors:  Barry Mook-Kanamori; Madelijn Geldhoff; Dirk Troost; Tom van der Poll; Diederik van de Beek
Journal:  BMC Infect Dis       Date:  2012-03-28       Impact factor: 3.090

10.  Method for inducing experimental pneumococcal meningitis in outbred mice.

Authors:  Damiana Chiavolini; Sergio Tripodi; Riccardo Parigi; Marco R Oggioni; Elisabetta Blasi; Marcella Cintorino; Gianni Pozzi; Susanna Ricci
Journal:  BMC Microbiol       Date:  2004-09-22       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.